Hurtsellers Christine
Transaction: 05/06/2026
BUY
Change
+163
Price
$37.38
Filing
05/07/2026
Type
BUY
John Hancock Financial Opportunities Fund
BTO • Asset Management
$40.15
▲ +0.08 (+0.20%)
Current price
EarningsLatest report: Dec 31, 2025
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$795.64M
Growth
17.4%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 106.1%Positive free cash flow · 0.47Consistent free cash flow · 5/5Reasonable earnings multiple · 9.93Manageable debt level · 0.18
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Feb 23, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$40.15
Change0.20%
Shares Out19.82M
Market Cap$795.64M
Enterprise Value$919.13M
52W Range32.01 - 39.85
Beta0.98
P/E3.77
P/S6.66
P/B1.11
P/FCF23.92
EV/Sales7.69
Price$40.15
Change0.20%
Shares Out19.82M
Market Cap$795.64M
Enterprise Value$919.13M
52W Range32.01 - 39.85
Beta0.98
P/E3.77
P/S6.66
P/B1.11
P/FCF23.92
EV/Sales7.69
EV/EBITDA4.09
EV/FCF27.63
Earnings Yield26.51%
FCF Yield4.18%
Dividend Yield12.40%
Gross Margin85.16%
Oper. Margin115.94%
Profit Margin106.13%
Debt/Eq0.18
Current Ratio0.00
Quick Ratio0.00
Revenue 5Y17.35%
Volume53.30K
Avg Volume47.20K
Investment DNA
How strong this company looks for long-term investors
65
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
61/100
Why this score▼
Stable or improving margins · 106.1%Positive free cash flow · 0.47Consistent free cash flow · 5/5Reasonable earnings multiple · 9.93Manageable debt level · 0.18Negative growth trend
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Phelan Kenneth J
Transaction: 01/26/2026
BUY
Change
—
Price
$37.10
Filing
01/27/2026
Type
BUY
Phelan Kenneth J
Transaction: 11/12/2025
OTHER
Change
0
Price
Not reported
Filing
11/17/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hurtsellers Christine | BUY | +163 | $37.38 | 05/06/2026 | 05/07/2026 |
| Phelan Kenneth J | BUY | — | $37.10 | 01/26/2026 | 01/27/2026 |
| Phelan Kenneth J | OTHER | 0 | Not reported | 11/12/2025 | 11/17/2025 |
| Hurtsellers Christine | OTHER | 0 | Not reported | 11/12/2025 | 11/17/2025 |
| Georgountzos Effie | OTHER | 0 | Not reported | 06/16/2025 | 07/31/2025 |
| Wright Thomas Rowe | BUY | +378 | $29.55 | 04/08/2025 | 04/09/2025 |
| Bacic William K | BUY | +288 | $34.70 | 01/14/2025 | 01/15/2025 |
| Ellison Noni L | BUY | +315 | $35.90 | 12/23/2024 | 12/26/2024 |
| Nataupsky Jeff | OTHER | 0 | Not reported | 10/31/2024 | 11/06/2024 |
| Carrington Patricia | OTHER | 0 | Not reported | 09/26/2024 | 10/02/2024 |
| Bacic William K | OTHER | 0 | Not reported | 08/01/2024 | 08/08/2024 |
| Wright Thomas Rowe | OTHER | 0 | Not reported | 08/01/2024 | 08/08/2024 |
| Silva Fernando A | OTHER | 0 | Not reported | 07/01/2024 | 07/02/2024 |
| McCubbin Terence A | OTHER | 0 | Not reported | 05/13/2024 | 05/15/2024 |
| Garfield Dean | BUY | — | $30.55 | 01/02/2024 | 01/04/2024 |
| Ellison Noni L | BUY | +100 | $24.48 | 10/12/2023 | 10/13/2023 |
| McFetridge Andy | OTHER | 0 | Not reported | 10/06/2023 | 10/10/2023 |
| Feinberg Kristie | OTHER | 0 | Not reported | 05/16/2023 | 05/23/2023 |
| Lo York | OTHER | 0 | Not reported | 12/15/2022 | 12/23/2022 |
| PRUCHANSKY STEVEN R | SELL | -1,091 | $37.94 | 08/05/2022 | 08/09/2022 |